pentobarbital will minimize the extent or impact of artemether/lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration with potent CYP3A4 inducers can result in lessened serum concentrations and loss of antimalarial efficacypentobarbital will decrease the level or outcome of estrogens